Company Filing History:
Years Active: 2023
Title: John P Morris, Iv: Innovator in Pancreatic Cancer Treatment
Introduction
John P Morris, Iv is a notable inventor based in New York, NY (US). He has made significant contributions to the field of cancer treatment, particularly focusing on pancreatic cancer. His innovative approach combines different therapeutic strategies to enhance patient outcomes.
Latest Patents
Morris holds a patent for a groundbreaking method titled "Combination therapy with MEK inhibitor and CDK4/6 inhibitor to treat pancreatic cancer." This technology provides methods for treating pancreatic cancer using a MEK inhibitor and a CDK4/6 inhibitor. The patent also discloses methods for increasing patient responsiveness to chemotherapeutic and/or immunotherapeutic regimes for pancreatic cancer. Additionally, kits for use in practicing these methods are included in the patent.
Career Highlights
Morris is affiliated with the Memorial Sloan Kettering Cancer Center, where he continues to work on innovative cancer therapies. His research focuses on improving treatment options for patients suffering from pancreatic cancer, a disease known for its challenging prognosis.
Collaborations
Morris collaborates with esteemed colleagues in his field, including Marcus Ruscetti and Scott William Lowe. Their combined expertise contributes to the advancement of cancer research and treatment methodologies.
Conclusion
John P Morris, Iv is a dedicated inventor whose work in pancreatic cancer treatment exemplifies the potential of innovative therapies. His contributions are paving the way for improved patient care and outcomes in oncology.